Asset Publisher

angle-left Robyn Tamblyn, MScN, M.Sc., PhD, CM

Senior Scientist, RI-MUHC

Cardiovascular Health Across the Lifespan Program

Centre for Outcomes Research and Evaluation

Professor, Department of Medicine, Faculty of Medicine, McGill University



Health services • medical education • medical informatics • practice changes • pharmacoepidemiology

Research Focus

My research focuses on conducting observational and interventional studies in public health and health services delivery aimed at improving the safety and quality of health care. My research program aims to identify modifiable determinants of adverse events and improved health outcomes through the analysis of large linked clinical and administrative databases. My team develops and evaluates computer-enabled interventions to address modifiable risk factors (e.g., computerized decision-support, personal health record portals and self-management tools, automated surveillance systems).

Selected Publications

Click on Pubmed to see my current publications list

  • Tamblyn R, Winslade N, Lee TC, Motulsky A, Meguerditchian A, Bustillo M, Elsayed S, Buckeridge D, Couture I, Qian C, Moraga T, Huang A. (Oct 11 2017) Improving patient safety and efficiency of medication reconciliation through the development and adoption of a computer-assisted tool with automated electronic integration of population-based community drug data: the RightRx project. Journal of the American Medical Informatics Association. Vol. 25(5):482-495.

  • Tamblyn R, Winslade N, Qian CJ, Moraga T, Huang A (2017) What is in your wallet? A cluster randomized trial of the effects of showing comparative patient out-of-pocket costs on primary care prescribing for uncomplicated hypertension. Implementation Science. Vol. 13:7.

  • Tamblyn R, Girard N, Qian CJ, Hanley J (April 23 2018) Assessment of potential bias in research grant peer review in Canada. Canadian Medical Association Journal. Vol.190:E489-99.

  • Eguale T, Buckeridge D, Verma A, Winslade N, Benedetti A, Hanley J, Tamblyn R.  (Jan 2016) The Association of Off-label Drug Use and Adverse Drug Events in an Adult Population. JAMA Internal Medicine. Vol. 176(1):55-63.

  • Tamblyn R, Girard N, Dixon WG, Haas JS, Bates DW, Sheppard T, Eguale T, Buckeridge D, Abrahamowicz M, Forster A. (Sept 2016) Pharmacosurveillance without borders: electronic health records in different countries can be used in estimating the risk of adverse events. Journal of Clinical Epidemiology. Vol. 77:101-111.